Results 131 to 140 of about 48,367 (253)

Pharmacological Interventions for Alcohol Withdrawal Syndrome Among Hospitalized Adults: A Multicenter Cohort Study. [PDF]

J Gen Intern Med
Erfle BA, Steel TL, Law AC, Kaufman DA, Hills-Dunlap K, Afshar M, Walkey AJ, Austad KE, Drainoni ML, Bosch NA.   +9 more
europepmc   +1 more source

Cannabinoid exposure during pregnancy: Cardiorespiratory effects and offspring outcomes

The Journal of Physiology, EarlyView.
Abstract figure legend Prenatal exposure to cannabinoids has been investigated across human and animal studies to understand its impact on physiological development. Evidence suggests that early‐life cannabinoid exposure influence multiple developmental processes, extending beyond neurodevelopmental outcomes to potentially affect placental function ...
Luis Gustavo A. Patrone, Luciane H. Gargaglioni   +1 more
wiley   +1 more source

Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome. [PDF]

J Pers Med, 2023
Ho TT, Noble M, Tran BA, Sunjic K, Gupta SV, Turgeon J, Crutchley RD.   +6 more
europepmc   +1 more source

Psychiatric and Cognitive Features in Italian Women With the FMR1 Premutation: A Comprehensive Assessment Using SCID‐5 and Standardized Cognitive Measures

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Volume 201, Issue 6, Page 406-419, September 2026.
ABSTRACT Women with the FMR1 premutation (PM) are at increased risk for fragile X‐associated conditions (FXPAC), including cognitive and psychiatric features collectively termed fragile X‐associated neuropsychiatric disorders (FXAND). This study is the first to systematically investigate cognitive and psychiatric features in Italian female premutation ...
Federica Alice Maria Montanaro, Randi J. Hagerman, Giuseppina Spano, Flora Tassone, Giancarlo Logroscino, Andrea Bosco   +5 more
wiley   +1 more source

Phenobarbital and Alcohol Withdrawal Syndrome: A Systematic Review and Meta-Analysis. [PDF]

Cureus, 2023
Umar Z, Haseeb Ul Rasool M, Muhammad S, Yousaf S, Nassar M, Ilyas U, Hosna AU, Parikh A, Bhangal R, Ahmed N, Ariyaratnam J, Trandafirescu T.   +11 more
europepmc   +1 more source

Assessing the Czech Version of the Inventory of Personality Organization in Relation to Borderline Personality Disorder in the ICD‐11

Journal of Clinical Psychology, Volume 82, Issue 9, Page 1313-1326, September 2026.
ABSTRACT Objectives This study assessed the Czech version of the Inventory of Personality Organization (IPO‐CZ) in relation to borderline personality disorder (BPD) as defined in the ICD‐11 model for PDs and defensive functioning in BPDs. The IPO‐CZ was used as a proxy measure of personality functioning (PF), although not fully identical to the ...
Karel D. Riegel, Albert J. Ksinan
wiley   +1 more source

Development of the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) Score as a Predictor of Alcohol Withdrawal Syndrome in Trauma Patients at a Community Level 1 Trauma Center. [PDF]

Cureus
Bottenfield M, Curfman K, Siddiqi S, Simunich T, Robinson A, Dumire R, Morrissey S.   +6 more
europepmc   +1 more source

Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Cannabinoid products are increasingly used worldwide despite limited psychiatric evidence. This narrative review synthesizes preclinical and clinical evidence on cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) to clarify their distinct psychiatric profiles and discuss how current evidence may inform ongoing clinical and ...
Yasuhiro Kishi, Ichiro Takumi, Kakusho Chigusa Nakajima‐Ohyama   +2 more
wiley   +1 more source

Appropriateness, feasibility, and adoption of a nurse-driven CIWA-Ar symptom-triggered protocol for alcohol withdrawal syndrome in New York City public hospitals. [PDF]

Am J Med Open
King C, Shen MS, Bayani J, Schatz D.
europepmc   +1 more source

Clinical characteristics and risk factors associated with consultation‐confirmed delirium in hospitalized patients

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Aim Delirium, a serious neuropsychiatric hospitalization complication, is a manifestation of underlying neurocognitive vulnerability rather than an acute event. In Japan, a nationwide medical policy mandates early hospital‐wide delirium risk screening to evaluate predefined risk factors in inpatient populations.
Megumi Matsuda, Kazuhiko Yamamuro, Masatsugu Ikeuchi, Akihiro Minami, Izumi Harada, Takahira Yamauchi, Tetsuro Kitamura, Yasuyo Kobayashi, Yukako Ishida, Yusuke Inagaki, Jyunko Minamiguchi, Akira Kido, Takashi Okada   +12 more
wiley   +1 more source